Speaking to CNBC, Ørnskov discusses Ozempic, Botox and the anti-aging boom, and what weight loss drugs mean for demand for Galderma's products.
Recap by typeshit. Full story at CNBC on MSN.
The EMA's CHMP amended its type 2 diabetes indication, and Italian diabetologists say Italy could be the first European country to offer the once-weekly combo.
26:19
A personal update from TakingWeightOff on life after stopping tirzepatide, three weeks in, and what caught them off guard.
Nyah Phengsitthy reports Lilly is staking out a new battlefront around an unapproved obesity treatment. The full story has the details.
A history of drug advertising, from opium-laced tonics and Radithor to the 1938 law after Elixir Sulfanilamide killed over 100 people. Semaglutide is mostly a hook.
A search page for retatrutide news with no specific story attached, so there is little new beyond recent coverage.
A TikTok poster shares lab results for Zepbound bought through Ro, reporting four metals under the detection limit. Details beyond that are thin.
Loading…